Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Self-Service A.I. Offered for Pathologists

A company in Finland is beginning a service that allows pathologists and researchers the ability to design their own artificial intelligence algorithms without writing code, for analyzing visual images of tissue samples. . . . → Read More: Self-Service A.I. Offered for Pathologists

Evotec Acquiring Sanofi Infectious Disease Portfolio

Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France. . . . → Read More: Evotec Acquiring Sanofi Infectious Disease Portfolio

Breathalyzer Biopsy Company Gains $15M in New Funds

A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital. . . . → Read More: Breathalyzer Biopsy Company Gains $15M in New Funds

Trials Test Antibodies to Prevent Hospital Infections

Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics. . . . → Read More: Trials Test Antibodies to Prevent Hospital Infections

Precision Cancer Drug Shown Effective in Adults, Children

Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs. . . . → Read More: Precision Cancer Drug Shown Effective in Adults, Children

Trial Shows Treatment Desensitizes Peanut Allergies

A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year. . . . → Read More: Trial Shows Treatment Desensitizes Peanut Allergies

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Open-Source Discovery Seeks Neglected Disease Drug

An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected. . . . → Read More: Open-Source Discovery Seeks Neglected Disease Drug

FDA Approves Wearable Epilepsy Seizure Detector

The U.S. Food and Drug Administration approved a device worn like a wristwatch that uses a machine-learning algorithm to detect convulsive seizures in people with epilepsy. . . . → Read More: FDA Approves Wearable Epilepsy Seizure Detector